ATE297987T1 - Bedingte immortalisierung von zellen - Google Patents
Bedingte immortalisierung von zellenInfo
- Publication number
- ATE297987T1 ATE297987T1 AT00960846T AT00960846T ATE297987T1 AT E297987 T1 ATE297987 T1 AT E297987T1 AT 00960846 T AT00960846 T AT 00960846T AT 00960846 T AT00960846 T AT 00960846T AT E297987 T1 ATE297987 T1 AT E297987T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- conditional immortalization
- recombinant
- conditionally
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99307405 | 1999-09-17 | ||
US09/663,537 US6399384B1 (en) | 1999-09-17 | 2000-09-15 | Conditional immortalization of cells |
PCT/GB2000/003588 WO2001021790A1 (en) | 1999-09-17 | 2000-09-18 | Conditional immortalisation of cells |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE297987T1 true ATE297987T1 (de) | 2005-07-15 |
Family
ID=26153574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00960846T ATE297987T1 (de) | 1999-09-17 | 2000-09-18 | Bedingte immortalisierung von zellen |
Country Status (11)
Country | Link |
---|---|
US (1) | US6399384B1 (de) |
EP (1) | EP1212420B1 (de) |
JP (1) | JP2003510046A (de) |
CN (1) | CN1373804A (de) |
AT (1) | ATE297987T1 (de) |
AU (1) | AU757816B2 (de) |
CA (1) | CA2383253A1 (de) |
DE (1) | DE60020855T2 (de) |
ES (1) | ES2241652T3 (de) |
IL (1) | IL148008A0 (de) |
WO (1) | WO2001021790A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
GB9907243D0 (en) * | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
DE10019195B4 (de) * | 2000-04-17 | 2006-03-09 | Heart Biosystems Gmbh | Reversible Immortalisierung |
US20050074747A1 (en) * | 2000-09-08 | 2005-04-07 | Wadih Arap | Biopanning and rapid analysis of selective interactive ligands (brasil) |
US20040170955A1 (en) * | 2000-09-08 | 2004-09-02 | Wadih Arap | Human and mouse targeting peptides identified by phage display |
US7452964B2 (en) * | 2001-09-07 | 2008-11-18 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides against placenta and adipose tissues |
US7420030B2 (en) * | 2000-09-08 | 2008-09-02 | The Board Of Regents Of The University Of Texas System | Aminopeptidase A (APA) targeting peptides for the treatment of cancer |
EP1207196A1 (de) * | 2000-10-27 | 2002-05-22 | Societe Des Produits Nestle S.A. | Immortalisierte pre-osteoblasten und verfahren zur deren herstellung |
WO2003007979A1 (en) * | 2001-07-18 | 2003-01-30 | Board Of Regents, The University Of Texas System | An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
US8507445B2 (en) * | 2001-09-07 | 2013-08-13 | Board Of Regents, The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
US20040048243A1 (en) * | 2001-09-07 | 2004-03-11 | Wadih Arap | Methods and compositions for in vitro targeting |
US7671010B2 (en) * | 2002-08-30 | 2010-03-02 | The Board Of Regents Of The University Of Texas System | Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer |
GB0125773D0 (en) * | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
US20050084959A1 (en) * | 2001-10-31 | 2005-04-21 | Hirofumi Hamada | Immortalized mesenchymal cells and utilization thereof |
US7943378B2 (en) * | 2002-03-15 | 2011-05-17 | Duke University | Tissue engineering |
KR20060003882A (ko) * | 2003-04-14 | 2006-01-11 | 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 하이브리도마 부재하의 폴리클로날 및 모노클로날 항체의생체외 제조 및 불멸화된 세포 집단의 생성 방법 |
EP1664098A1 (de) * | 2003-09-12 | 2006-06-07 | Reneuron Limited | Immortalisierung von säugetierzellen und therapeutische anwendungen für diese zellen |
US20050193432A1 (en) * | 2003-11-18 | 2005-09-01 | Whitehead Institute For Biomedical Research | Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof |
DK1645626T3 (da) | 2004-09-30 | 2008-01-21 | Reneuron Ltd | Cellelinie |
US20090298095A1 (en) | 2005-04-15 | 2009-12-03 | The John Hopkins University | Immortalization of cells including neuronal cells |
EA019505B1 (ru) * | 2005-12-16 | 2014-04-30 | Рибовакс Байотекнолоджиз Са | Способ получения иммортализованных клеток, секретирующих антитела, популяция иммортализованных клеток и ее применения |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
EP2380905A1 (de) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipidangereicherte Vesikel mit Gewebefaktor mit blutstillenden Aktivitäten sowie Verwendungen davon |
CN105176913A (zh) * | 2015-09-23 | 2015-12-23 | 扬州大学 | 一种奶牛乳腺上皮细胞永生化方法 |
EP3894546A4 (de) * | 2018-12-16 | 2022-12-21 | Figene, LLC | Therapeutische verwendungen von geneditierten fibroblasten |
GB202005494D0 (en) | 2020-04-15 | 2020-05-27 | Reneuron Ltd | Induced pluripotent cell comprising a contollable transgene for conditional immortalisation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270191A (en) * | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5766948A (en) | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
WO1996019580A2 (en) | 1994-12-19 | 1996-06-27 | Cold Spring Harbor Laboratory | Telomerase protein component |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
IL129103A0 (en) | 1996-10-01 | 2000-02-17 | Geron Corp | Human telomerase catalytic subunit and pharmaceutical compositions containing same |
WO1998037181A2 (en) | 1997-02-20 | 1998-08-27 | Whitehead Institute For Biomedical Research | Telomerase catalytic subunit gene and encoded protein |
-
2000
- 2000-09-15 US US09/663,537 patent/US6399384B1/en not_active Expired - Fee Related
- 2000-09-18 DE DE60020855T patent/DE60020855T2/de not_active Expired - Lifetime
- 2000-09-18 IL IL14800800A patent/IL148008A0/xx unknown
- 2000-09-18 AT AT00960846T patent/ATE297987T1/de not_active IP Right Cessation
- 2000-09-18 JP JP2001525348A patent/JP2003510046A/ja active Pending
- 2000-09-18 AU AU73015/00A patent/AU757816B2/en not_active Ceased
- 2000-09-18 CA CA002383253A patent/CA2383253A1/en not_active Abandoned
- 2000-09-18 EP EP00960846A patent/EP1212420B1/de not_active Expired - Lifetime
- 2000-09-18 ES ES00960846T patent/ES2241652T3/es not_active Expired - Lifetime
- 2000-09-18 CN CN00812878A patent/CN1373804A/zh active Pending
- 2000-09-18 WO PCT/GB2000/003588 patent/WO2001021790A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU7301500A (en) | 2001-04-24 |
DE60020855T2 (de) | 2006-05-04 |
CN1373804A (zh) | 2002-10-09 |
US6399384B1 (en) | 2002-06-04 |
ES2241652T3 (es) | 2005-11-01 |
CA2383253A1 (en) | 2001-03-29 |
EP1212420A1 (de) | 2002-06-12 |
AU757816B2 (en) | 2003-03-06 |
JP2003510046A (ja) | 2003-03-18 |
WO2001021790A1 (en) | 2001-03-29 |
EP1212420B1 (de) | 2005-06-15 |
DE60020855D1 (de) | 2005-07-21 |
IL148008A0 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE297987T1 (de) | Bedingte immortalisierung von zellen | |
DK1280898T3 (da) | Modificerede ES-celler og ES-cellespecifikt gen | |
DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
GB0706626D0 (en) | Medium and culture of embryonic stem cells | |
HK1091228A1 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
ATE394496T1 (de) | Herstellung von sekretierten proteinen durch rekombinante eukaryotische zellen | |
ATE342275T1 (de) | Vorübergehend-immortalisierte zellen zur verwendung in gentherapie | |
MXPA03007829A (es) | Catodos de pila de combustible novedosos y sus pilas de combustible. | |
ATE391175T1 (de) | Multidrug resistenz gen | |
DK1137808T3 (da) | Fremgangsmåde til fremstilling af rekombinante celler | |
DE602005023181D1 (de) | Lentivirusvektoren und deren verwendung | |
DK1032672T3 (da) | DNA19355-polypeptid, en tumornekrosefaktor-homolog | |
ATE326537T1 (de) | Schnell erzeugung von stabilen säugertier- zellinien mit gewinnung eines hohen gehalts von recombinanten proteine | |
DK1131408T3 (da) | Celler, dyrkningsmetoder og deres anvendelse ved autolog transplantationsbehandling | |
ATE226087T1 (de) | Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon | |
FR2716205B1 (fr) | Récepteur galanine, acides nucléiques, cellules transformées et utilisations. | |
DE69515652D1 (de) | Verwendung von dna oligomeren zur hemmung von hiv durch reduktion ribosomaler leserasterverschichtung | |
AR020208A1 (es) | Construcciones de adn | |
ATE359372T1 (de) | Vektoren zur inhibierung von viralem und tumorwachstum | |
BR0014489B1 (pt) | processo de produÇço de adenovÍrus, e, kit. | |
FI972909A0 (fi) | Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller | |
DE50311218D1 (de) | Verwendung von glutaminfreien medium | |
WO2000053759A8 (en) | Expression of human alpha-fetoprotein in mammalian cells | |
MY136860A (en) | Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium | |
DE69939825D1 (de) | Genetische transduktion von hämatopoietische vorläuferzellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1212420 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |